FindTrial
Sign In

The application of soluble triggering receptor expressed on myeloid cells-1 in sepsis

A prospective study on the diagnosis and prognosis of soluble triggering receptor expressed on myeloid cells-1 in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-09000745
Enrollment
Unknown
Registered
2009-12-07
Start date
2009-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis/ventilator associated pneumonia/urinary infection

Interventions

SIRS group:none
Septic shock group:none
Severe sepsis group:none
Sepsis group:none

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 years old and over; 2. clinically suspected infection; 3. fulfilled at least two criterias of systemic inflammatory response syndrome (1) core temperature higher than 38 degree C or lower than 36 degree C (2) respiratory rate above 20/min, or PCO2 below 32 mmHg (3) pulse rate above 90/min, and (4) white blood cell count greater than 12,000/ul or lower than < 4,000/ul or less than 10% of bands.

Exclusion criteria

Exclusion criteria: Those who fulfilled one below: (1) neutropenia (<=500 neutrophils/mm3), (2) HIV infectn, and (3) patients or their ralatives refused.

Design outcomes

Primary

MeasureTime frame
outcome when out of ICU;Median length of ICU stay;—

Secondary

MeasureTime frame
28-day survival;Median soluble TREM-1 level;—

Countries

China

Contacts

Public ContactLixin Xie
xielx@263.net+86 010 66937192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026